Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000096

Chief Executive Officer sold 75,000 shares at an average $26.14 ($1,960,601)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Congleton Jon Chief Executive Officer 2026-06-30 Sale 10b5-1 −58,000 $25.94 $1,504,706 631,321 D
Congleton Jon Chief Executive Officer 2026-06-30 Sale 10b5-1 −17,000 $26.82 $455,896 614,321 D
Open-market sales · 75,000 sh · avg $26.14 · $1,960,601
Loading xslF345X06/wk-form4_1782859282.xml…